President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Denmark Election 2025: Social Democrats Suffer Historic Losses Amid Migration and Cost-of-Living Tensions
US Accelerates Taiwan Arms Deliveries Amid Rising China Threat
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
U.S.-Iran Peace Talks Gain Momentum Amid Ongoing Conflict
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Taiwan Arms Deal on Track Despite U.S.-China Summit Uncertainty
Trump Backs Down on Iran Strikes After Gulf Allies Sound the Alarm 



